Form 8-K - Current report:
SEC Accession No. 0001104659-24-122350
Filing Date
2024-11-25
Accepted
2024-11-25 06:45:19
Documents
15
Period of Report
2024-11-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428770d1_8k.htm   iXBRL 8-K 29130
2 EXHIBIT 99.1 tm2428770d1_99-1.htm EX-99.1 4757
6 GRAPHIC tm2428770d1_99-1img001.jpg GRAPHIC 10251
  Complete submission text file 0001104659-24-122350.txt   225236

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20241125.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20241125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20241125_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428770d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 241491887
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)